author_facet Mamouei, Zeinab
Alqarihi, Abdullah
Singh, Shakti
Xu, Shuying
Mansour, Michael K.
Ibrahim, Ashraf S.
Uppuluri, Priya
Mamouei, Zeinab
Alqarihi, Abdullah
Singh, Shakti
Xu, Shuying
Mansour, Michael K.
Ibrahim, Ashraf S.
Uppuluri, Priya
author Mamouei, Zeinab
Alqarihi, Abdullah
Singh, Shakti
Xu, Shuying
Mansour, Michael K.
Ibrahim, Ashraf S.
Uppuluri, Priya
spellingShingle Mamouei, Zeinab
Alqarihi, Abdullah
Singh, Shakti
Xu, Shuying
Mansour, Michael K.
Ibrahim, Ashraf S.
Uppuluri, Priya
mSphere
Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
Molecular Biology
Microbiology
author_sort mamouei, zeinab
spelling Mamouei, Zeinab Alqarihi, Abdullah Singh, Shakti Xu, Shuying Mansour, Michael K. Ibrahim, Ashraf S. Uppuluri, Priya 2379-5042 American Society for Microbiology Molecular Biology Microbiology http://dx.doi.org/10.1128/msphere.00539-18 <jats:p> The prevalence of fungal infections has seen a rise in the past decades due to advances in modern medicine leading to an expanding population of device-associated and immunocompromised patients. Furthermore, the spectrum of pathogenic fungi has changed, with the emergence of multidrug-resistant strains such as <jats:named-content content-type="genus-species">C. auris</jats:named-content> . High mortality related to fungal infections points to major limitations of current antifungal therapy and an unmet need for new antifungal drugs. We screened a library of repurposed FDA-approved inhibitors to identify compounds with activities against a diverse range of fungi in varied phases of growth. The assays identified alexidine dihydrochloride (AXD) to have pronounced antifungal activity, including against preformed biofilms, at concentrations lower than mammalian cell toxicity. AXD potentiated the activity of fluconazole and amphotericin B against <jats:italic>Candida</jats:italic> biofilms <jats:italic>in vitro</jats:italic> and prevented biofilm growth <jats:italic>in vivo</jats:italic> . Thus, AXD has the potential to be developed as a pan-antifungal, antibiofilm drug. </jats:p> Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens mSphere
doi_str_mv 10.1128/msphere.00539-18
facet_avail Online
Free
finc_class_facet Biologie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9tc3BoZXJlLjAwNTM5LTE4
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9tc3BoZXJlLjAwNTM5LTE4
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint American Society for Microbiology, 2018
imprint_str_mv American Society for Microbiology, 2018
issn 2379-5042
issn_str_mv 2379-5042
language English
mega_collection American Society for Microbiology (CrossRef)
match_str mamouei2018alexidinedihydrochloridehasbroadspectrumactivitiesagainstdiversefungalpathogens
publishDateSort 2018
publisher American Society for Microbiology
recordtype ai
record_format ai
series mSphere
source_id 49
title Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_unstemmed Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_full Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_fullStr Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_full_unstemmed Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_short Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_sort alexidine dihydrochloride has broad-spectrum activities against diverse fungal pathogens
topic Molecular Biology
Microbiology
url http://dx.doi.org/10.1128/msphere.00539-18
publishDate 2018
physical
description <jats:p> The prevalence of fungal infections has seen a rise in the past decades due to advances in modern medicine leading to an expanding population of device-associated and immunocompromised patients. Furthermore, the spectrum of pathogenic fungi has changed, with the emergence of multidrug-resistant strains such as <jats:named-content content-type="genus-species">C. auris</jats:named-content> . High mortality related to fungal infections points to major limitations of current antifungal therapy and an unmet need for new antifungal drugs. We screened a library of repurposed FDA-approved inhibitors to identify compounds with activities against a diverse range of fungi in varied phases of growth. The assays identified alexidine dihydrochloride (AXD) to have pronounced antifungal activity, including against preformed biofilms, at concentrations lower than mammalian cell toxicity. AXD potentiated the activity of fluconazole and amphotericin B against <jats:italic>Candida</jats:italic> biofilms <jats:italic>in vitro</jats:italic> and prevented biofilm growth <jats:italic>in vivo</jats:italic> . Thus, AXD has the potential to be developed as a pan-antifungal, antibiofilm drug. </jats:p>
container_issue 5
container_start_page 0
container_title mSphere
container_volume 3
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348913767809036
geogr_code not assigned
last_indexed 2024-03-01T18:18:44.93Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Alexidine+Dihydrochloride+Has+Broad-Spectrum+Activities+against+Diverse+Fungal+Pathogens&rft.date=2018-10-31&genre=article&issn=2379-5042&volume=3&issue=5&jtitle=mSphere&atitle=Alexidine+Dihydrochloride+Has+Broad-Spectrum+Activities+against+Diverse+Fungal+Pathogens&aulast=Uppuluri&aufirst=Priya&rft_id=info%3Adoi%2F10.1128%2Fmsphere.00539-18&rft.language%5B0%5D=eng
SOLR
_version_ 1792348913767809036
author Mamouei, Zeinab, Alqarihi, Abdullah, Singh, Shakti, Xu, Shuying, Mansour, Michael K., Ibrahim, Ashraf S., Uppuluri, Priya
author_facet Mamouei, Zeinab, Alqarihi, Abdullah, Singh, Shakti, Xu, Shuying, Mansour, Michael K., Ibrahim, Ashraf S., Uppuluri, Priya, Mamouei, Zeinab, Alqarihi, Abdullah, Singh, Shakti, Xu, Shuying, Mansour, Michael K., Ibrahim, Ashraf S., Uppuluri, Priya
author_sort mamouei, zeinab
container_issue 5
container_start_page 0
container_title mSphere
container_volume 3
description <jats:p> The prevalence of fungal infections has seen a rise in the past decades due to advances in modern medicine leading to an expanding population of device-associated and immunocompromised patients. Furthermore, the spectrum of pathogenic fungi has changed, with the emergence of multidrug-resistant strains such as <jats:named-content content-type="genus-species">C. auris</jats:named-content> . High mortality related to fungal infections points to major limitations of current antifungal therapy and an unmet need for new antifungal drugs. We screened a library of repurposed FDA-approved inhibitors to identify compounds with activities against a diverse range of fungi in varied phases of growth. The assays identified alexidine dihydrochloride (AXD) to have pronounced antifungal activity, including against preformed biofilms, at concentrations lower than mammalian cell toxicity. AXD potentiated the activity of fluconazole and amphotericin B against <jats:italic>Candida</jats:italic> biofilms <jats:italic>in vitro</jats:italic> and prevented biofilm growth <jats:italic>in vivo</jats:italic> . Thus, AXD has the potential to be developed as a pan-antifungal, antibiofilm drug. </jats:p>
doi_str_mv 10.1128/msphere.00539-18
facet_avail Online, Free
finc_class_facet Biologie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEyOC9tc3BoZXJlLjAwNTM5LTE4
imprint American Society for Microbiology, 2018
imprint_str_mv American Society for Microbiology, 2018
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 2379-5042
issn_str_mv 2379-5042
language English
last_indexed 2024-03-01T18:18:44.93Z
match_str mamouei2018alexidinedihydrochloridehasbroadspectrumactivitiesagainstdiversefungalpathogens
mega_collection American Society for Microbiology (CrossRef)
physical
publishDate 2018
publishDateSort 2018
publisher American Society for Microbiology
record_format ai
recordtype ai
series mSphere
source_id 49
spelling Mamouei, Zeinab Alqarihi, Abdullah Singh, Shakti Xu, Shuying Mansour, Michael K. Ibrahim, Ashraf S. Uppuluri, Priya 2379-5042 American Society for Microbiology Molecular Biology Microbiology http://dx.doi.org/10.1128/msphere.00539-18 <jats:p> The prevalence of fungal infections has seen a rise in the past decades due to advances in modern medicine leading to an expanding population of device-associated and immunocompromised patients. Furthermore, the spectrum of pathogenic fungi has changed, with the emergence of multidrug-resistant strains such as <jats:named-content content-type="genus-species">C. auris</jats:named-content> . High mortality related to fungal infections points to major limitations of current antifungal therapy and an unmet need for new antifungal drugs. We screened a library of repurposed FDA-approved inhibitors to identify compounds with activities against a diverse range of fungi in varied phases of growth. The assays identified alexidine dihydrochloride (AXD) to have pronounced antifungal activity, including against preformed biofilms, at concentrations lower than mammalian cell toxicity. AXD potentiated the activity of fluconazole and amphotericin B against <jats:italic>Candida</jats:italic> biofilms <jats:italic>in vitro</jats:italic> and prevented biofilm growth <jats:italic>in vivo</jats:italic> . Thus, AXD has the potential to be developed as a pan-antifungal, antibiofilm drug. </jats:p> Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens mSphere
spellingShingle Mamouei, Zeinab, Alqarihi, Abdullah, Singh, Shakti, Xu, Shuying, Mansour, Michael K., Ibrahim, Ashraf S., Uppuluri, Priya, mSphere, Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens, Molecular Biology, Microbiology
title Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_full Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_fullStr Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_full_unstemmed Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_short Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
title_sort alexidine dihydrochloride has broad-spectrum activities against diverse fungal pathogens
title_unstemmed Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens
topic Molecular Biology, Microbiology
url http://dx.doi.org/10.1128/msphere.00539-18